nafamostat has been researched along with fibrinopeptide a in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kondo, C; Kusagawa, M; Nasu, M; Okada, Y; Sato, T; Shomura, T; Tanaka, K; Yada, I; Yuasa, H | 1 |
1 other study(ies) available for nafamostat and fibrinopeptide a
| Article | Year |
|---|---|
Hematological problems during the use of cardiac assist devices: clinical experiences in Japan.
Topics: Aged; Anticoagulants; Antithrombin III; Benzamidines; Blood Coagulation; Female; Fibrinopeptide A; Guanidines; Heart-Assist Devices; Hemostasis; Humans; Japan; Male; Middle Aged; Peptide Hydrolases; Shock, Cardiogenic; Thrombosis | 1992 |